triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial Lilly's triple achieves 16.8% weight loss in 3 retatrutide phase 2 trial obesity
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26


























